That's essential, because the method a protein in the human body folds figures out if a pharmaceutical will be able to bind to that protein and work. In other words, we need to know how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error process (jeff brown predictions 2021). But now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it much easier to develop drugs that do what they're developed to do. This was a development nearly no one observed. However it's going to have extensive ramifications for curing disease. I anticipate that Alpha, Fold will be 98% precise by the end of 2021.
And, naturally, there will be lots of investment opportunities in this area, too. Shifting subjects It's going to be a great year for bitcoin. I'm bullish on it in 2021 (jeff brown 1 biotech). That stated, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe significantly before going higher - biotech stocks jeff brown. I have actually been covering bitcoin for a long time now. One of the very first research study reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that preliminary recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were primarily educating readers. However that's not the huge concern any longer. Now we're seeing institutional money finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some small, niche enterprise. Mass, Mutual is a relied on 170-year-old organization. So think of that. In 5 years, we went from informing readers on what bitcoin is to a business like Mass, Mutual taking a $100 million stake.
And that's a huge reason I'm bullish on it this year. tech stocks. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. companies went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I predict 2021 will be another record year in IPOs. There are many excellent personal companies on the brink of hitting the general public markets And I have actually been working on a new way for you to invest even before these companies go public.
This chance has actually been developing over the last few years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to reserve your spot for totally free.
Emma Walsh here, handling editor of the Diary. Regular Diary readers know that tech isn't our usual beat (self-driving cars). And when it pertains to tech investing, we leave it to the experts. Thankfully, we have several such experts in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is among the most accomplished tech investing specialists we know (jeff brown). In fact, he had several triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff believes the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and forecast what's just around the corner.
That consists of things like 5G networks, biotech, expert system, and much more. These trends are experiencing rapid growth and producing extraordinary chances for financiers. I wish to ensure all our readers are prepared for what's next. And with that in mind, let me draw the photo of what I see being available in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a topic I have actually been covering for years now. toxic tech 5 tech darlings. But in spite of what lots of readers may believe, this is a pattern that's just getting going. Despite the fact that the COVID-19 pandemic interrupted supply chains in 2015, an impressive 250 million 5G-enabled devices were still sold.
And all of this ultimately caused Apple postponing the release of the 5G-enabled i, Phone 12 by 2 months (diplomatic relations). Losing two months of production and sales really affects the number of 5G devices are sold in the calendar year. When you think about all of that, offering 250 million systems is impressive. More notably, the delays triggered by the pandemic developed a lots of pent-up need. And that demand is now going to be pressed into 2021. In fact, I predict that more than 500 million 5G devices will be shipped in 2021 - jeff brown prediction. And that's not my only 5G prediction When I have actually discussed 5G in the past, I've described its 3 various phases.
In Phase 2, 5G devices go on sale. 5G phones and other products start to reach customers. And in Stage 3, 5G services begin to be used (jeff brown genome sequencing). That's when we begin to see applications operating on 5G networks. Think about things like huge multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Stage Three by this summer season. This starts something of a virtuous cycle: Many people do not actually appreciate the innovation. However they will care if there are exciting applications that can just be accessed with a 5G phone.
That leads to more 5G apps being developed. In reality, 5G is going to open up a suite of incredible applications: self-driving automobiles, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The investment opportunities going forward will be massive. Stepping far from 5G, the next important technology I anticipate in 2021 is CRISPR genetic modifying. CRISPR stands for "clustered frequently interspaced short palindromic repeat." It's a mouthful. However it's one of the most amazing developments in biotechnology. At a high level, CRISPR is an innovation that can modify our genetic makeup as if it were software application.
The program can crash or not operate properly. CRISPR utilizes a similar idea however with our genetic code. "Typos" in our genome can result in disease. CRISPR can correct these "typos." For several years, CRISPR was mostly a niche innovation that wasn't well comprehended. And throughout that time, there were truly only 3 companies running in this space. However things are altering. CRISPR is no longer simply theoretical. We're seeing real outcomes. We're dealing with illness and seeing that this technology simply works. And as an outcome, a "2nd crop" of early-stage CRISPR companies is going public and providing amazing returns. This entire industry is effectively a greenfield opportunity.
There's space for many companies to exist in this area. self-driving cars. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or three more hereditary modifying business will hold their IPOs. Sticking to biotechnology, we are seeing amazing things taking place at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its latest Alpha, Fold software application can accurately predict the folding of a protein based solely on its amino acid sequence with 92. 4% accuracy. That's essential since the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be efficient.
Historically, this has actually been a trial-and-error process. Today, Alpha, Fold can anticipate protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're created to do. And here's my next prediction. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one but numerous drug treatments produced utilizing this technology. This was among those developments that almost no one saw. But it's going to have extensive implications for curing disease. And, obviously, there will be lots of financial investment opportunities in this area, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I wouldn't be shocked if it pulled back perhaps significantly before going higher. I've been covering bitcoin for a very long time now. One of the first research study reports I ever released was on bitcoin - artificial intelligence. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for any person who followed my suggestion. However at the time of that initial suggestion, I titled my report, "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time.
But no one is asking that concern any longer. Now, we're seeing institutional cash finally taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. democratic republic. Mass, Mutual is a 150-year-old organization. So think of that. In 5 years, we went from educating readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a huge reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus offer forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the information depends on date as of February 2021, but we might not separately validate this claim. Offered Jeff Brown's past, he likely has a substantial net worth, but we can't hammer down a precise figure at this minute. Brown is best understood for his sage-like ability to choose winning innovation stocks. He spent more than 25 years looking into technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an exceptional viewpoint on the marketplace. He's always on the hunt for new chances, and he shares much of his finest choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an excellent track record as a stock-picker, and he successfully forecasted a few of the biggest financial events of the previous twenty years. Although he does not appear to launch his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it best every time, however Jeff Brown's accurate forecasts have actually made him legions of devoted followers. That says a lot about his capability. The Future Report is published by Brownstone Research study, a prominent financial research publisher. Brownstone Research study uses a number of research study services with a variety of expertises - jeff brown genetic sequencer stock.
The business is also affiliated with Bonner & Partners, another well-respected research publisher - social media. On its site, Brownstone states its mission is to supply retail investors with professional-grade research study: "For too long, the very best investment research study has not been offered to individual financiers. It has been generally scheduled for investment banks, hedge funds, private equity, and high-net-worth clients. the legacy report predictions. The mission of Brownstone Research study is to make that type of exclusive research available to any financiers looking to acquire an edge in the markets. The objective is basic to deliver special and rewarding investment research study found nowhere else." -Brownstone Research study website excerpt from the Jeff Brown is the founder of Brownstone Research study, and he also serves as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research study is a powerhouse publisher with lots to provide its clients. After decades of stable success at the helm of top-tier companies like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you understand even a little bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. jeff brown top biotech 2020. Whatever he touches relies on gold! Jeff is well mindful of Elon Musk's executive prowess, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next huge task.
In fact, Brown thinks S.A.V. jeff brown market predictions. could be "the biggest trend of the 2020s, and he's not alone. Check out these quotes from other well-known S.A.V. bulls: Elon's next huge act will be weding 2 cutting-edge technologies: expert system and electric cars. Musk hopes the mix will assist him establish the very first fully-autonomous, self-driving vehicles ever. It's absolutely nothing except the vehicle market's Holy Grail. As you know, electric vehicles and self-driving cars and truck stocks have been big this year, however the Wall Street maker has approved buzz without much concrete outcome. In spite of an extreme boost in competitors over the past few years, Brown still thinks Musk has the very best possibility of putting everything together.
tech might be the magic string that ties it all together. S.A.V. means Shared Autonomous Vehicle, and it could be the future of transport. Essentially, this technology would permit you to rent out your vehicle as a self-governing, self-driving taxi when you're not utilizing it. You simply get out of the vehicle and press a button on an app that informs the car to "sign up with the fleet." Next thing you understand, you're relaxing on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a hefty piece of the revenues. It sounds insane, however it could be closed than you think.